Amgen kept by Bear Stearns at peer perform

Amgen Inc. was maintained by Bear Stearns analyst Mark Schoenebaum at a peer perform rating following second-quarter earnings. Bear Stearns' short-term bias on the stock remains positive as Amgen's base business is strong and pipeline visibility is improving, but sees the stock could cool off in late 2005 to early 2006 when news flow around potential competition intensifies. Amgen shares Wednesday jumped $10.65, or 15.10%, to $81.17 on volume of 81,042,901 shares versus the three-month running average of 8,010,400 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.